Home » Topics » BioWorld Science

BioWorld Science
RSS

Mindset reports new benchmarking data on first-generation psychedelics

Feb. 18, 2022

EBV antibodies put to good use through retargeting

Feb. 18, 2022

Targeting PFKFB3 reduces the severity of colitis in mouse models

Feb. 18, 2022

New biomarkers identified to predict response to vedolizumab in patients with Crohn's disease

Feb. 18, 2022

Targeting GDNF may have potential to treat IBD

Feb. 18, 2022

Nrf2 agonists ameliorate anemia of inflammation by disrupting the hepcidin-ferroportin axis

Feb. 18, 2022

Using photoactivatable peptide toxins for modulation of voltage-gated ion channels

Feb. 18, 2022

Broadly neutralizing HCV antibodies isolated from high responders used to design new antibody

Feb. 18, 2022

Neurophilin-1 is an inhibitor of HIV-1 infectivity

Feb. 18, 2022

New HSD17B13 inhibitors identified at Inipharm

Feb. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...